Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-01

Clinical Trial Update: Efficacy of Liposomal Bupivacaine for Prolonged Postoperative Analgesia in Patient Undergoing Breast Reconstruction With Tissue Expander [Phase 4]

View source ↗

Summary

Phase 4 trial assessing liposomal bupivacaine for prolonged postoperative analgesia in breast reconstruction with tissue expander; results posted after completi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Pain, Postoperative, Mammaplasty | Phase 4 | Status: COMPLETED | Results posted: 2022-07-01